TrialBone marrow transplantation2006

High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol.

E Jantunen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.